LP-184
LP-184 is a small-molecule inhibitor from Lantern Pharma Inc., in registered phase 2 trials for triple-negative breast cancer, non-small-cell lung cancer, pancreatic ductal adenocarcinoma.
Overview
LP-184 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Lantern Pharma Inc., in triple-negative breast cancer, non-small-cell lung cancer, pancreatic ductal adenocarcinoma. Described in the registry record as a small-molecule inhibitor; the trial entries below carry the sponsor's wording. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
Described in the registry record as a small-molecule inhibitor; the trial entries below carry the sponsor's wording.
1.LP-184 slips into a pocket on its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"LP-184" OR ABSTRACT:"LP-184") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about LP-184, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentJMT203
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentAdavosertib
Shares Triple-negative breast cancer (TNBC) and the tags pipeline, registry-only.
- TreatmentCT3001
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.
- TreatmentPBP1510
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.
- TreatmentTenalisib
Shares Triple-negative breast cancer (TNBC) and the tags pipeline, registry-only.
- TreatmentMitazalimab
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.
- TreatmentTQB2868
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.
- TreatmentBoserolimab
Shares Non-small-cell lung cancer and the tags pipeline, registry-only.